Press Releases

 

NanoSight Announces a New Generation Nanoparticle Characterisation System - the NanoSight NS500

Salisbury, UK, 2nd February 2010: NanoSight, manufacturers of unique nanoparticle characterisation technology, announces the release of the NS500 system. The NS500 incorporates new hardware and software to deliver NanoSight’s growing capability in particle-by-particle characterisation, in an automated package. The first system is in use at the University of Oxford in the Nuffield Department of Obstetrics and Gynaecology of the John Radcliffe Hospital as part of a program supported by the Wellcome Foundation.
read more


 

Brigham Young University Selects NanoSight to Support Research in the Synthesis of Inorganic Nanoparticles 

Salisbury, UK, 26th January 2010: The Department of Chemistry & Biochemistry at Brigham Young University (BYU) has chosen the NanoSight LM10 system to support their research into the synthesis of inorganic nanoparticles, principally metal oxides.
read more


 

Georgia Institute of Technology Selects Nanosight to Study the Size of Nanogels Used in Developing Drug Delivery Vehicles.

Salisbury, UK, January 2010: The School of Chemistry & Biochemistry at Georgia Institute of Technology has chosen the NanoSight LM-20 system to help in the characterisation of dimensional changes of nanogels used in the development of drug delivery vehicles for macromolecular therapeutics.
read more


 

NanoSight short-listed in 2009 Business Innovation Awards at the UK NanoForum recognising their contribution to nanometrology. 

Salisbury, UK, 4th November 2009: This week, NanoSight, providers of unique nanoparticle characterisation technology, attended the fourth annual UK NanoForum & Emerging Technologies conference and exhibition which brought together over 100 senior international delegates and 350 UK delegates to network and identify potential business and collaboration opportunities in the world of nanotechnology.
read more


 

Registration is now open for a virus webinar from NanoSight: A Novel Viral Titre and Characterisation Tool – NTA (Nanoparticle Tracking Analysis)

Salisbury, UK, October 2009: NanoSight, manufacturers of unique nanoparticle characterisation technology, announces a webinar on Tuesday 10th November, 3pm UK time and then repeated at 5pm UK time (1000 EST, then 1200 EST/0900 Pacific Time). NanoSight has developed a new technique which is gaining much interest in the area of viral vaccine development and phage therapeutics.
read more


 

Strathclyde's Nanometrology Centre Select NanoSight for the Characterisation of Nanoparticles to Develop New Biosensors

Salisbury, UK, October 2009: NanoSight, manufacturers of unique nanoparticle characterisation technology, has announced that the Centre for Molecular Nanometrology at the University of Strathclyde has selected an LM-10 characterisation system to aid in their research and development of new biosensors.
read more


 

Henderson Morely PLC Selects NanoSight Instrumentation for Rapid Virus Titre Assessment

Salisbury, UK, September 2009: NanoSight, manufacturers of unique nanoparticle characterization technology, announce that UK biotechnology company, Henderson Morley plc, is using nanoparticle tracking analysis (NTA) to quantify virus particle number for batch to batch control.
read more


 

Leading Japanese Research Institute selects Nanosight for the Study of Nanobubbles

Salisbury, UK, June 2009: - NanoSight, manufacturers of unique nanoparticle characterization technology, are happy to report that Kaneo Chiba and Masayoshi Takahashi of Japan's famous AIST research centre are using nanoparticle tracking analysis (NTA) technology to characterize nanobubbles.
read more


 

NanoSight to supply breakthrough instrumentation for Wellcome Trust Technology Development Grant awarded to Human Diseases Research Team from University of Oxford

Amesbury, UK, May 2009: NanoSight, manufacturers of unique nanoparticle characterization technology, are very proud to announce their close involvement in the research and development of a new generation of novel instrumentation and methodologies aimed at measuring cellular nanoparticles in plasma and urine as biomarkers of a broad range of human disease conditions.
read more


 

Shackleton Ventures completes further investment in NanoSight

February 2009 - Shackleton Ventures Limited (Shackleton), the secondaries venture capital firm, today announces that it has completed a follow-on investment in one of its portfolio companies, NanoSight Limited, with the purchase of a significant shareholding from the National Endowment for Science, Technology & Arts (NESTA) for an undisclosed amount.
read more.


 

NanoSight starts 2009 in new Amesbury location with a new sales manager

Amesbury, UK, January 2009 - NanoSight, the UK nanoparticle characterization company, has moved into new buildings in Amesbury, Wiltshire. The move provides increased space and a platform for increased growth in the coming years. The company is also happy to announce the appointment of Julie Downsborough as sales manager.
read more.


 

NanoSight launches new super-sensitive nanoparticle characterization system, the LM10-HS

Amesbury, UK, January 2009 - NanoSight, the UK nanoparticle characterization company, announces the release of a new super-sensitive system to compliment their range of instruments for imaging and sizing nanoparticles in liquid suspension. The system utilizes EMCCD camera technology (Electron Multiplication Charge Coupled Device) which has improved the sensitivity of the standard Nanosight system by a factor of x100. In practical terms, this means that the lower limit of detection for a particular particle type has been improved by a factor of two when compared to the standard LM10 system.
read more.


 

NanoSight nanoparticle detection technique contributes to virus production to counter MRSA

Salisbury, UK, November 2008 - Virus particle detection and counting using Nanoparticle Tracking Analysis is providing essential information for researchers at the University of Strathclyde’s Institute of Pharmacy and Biomedical Sciences (SIPBS). This team develops methods to employ naturally-occurring bacteriophages to combat MRSA and other bacteria. MRSA or Methicillin resistant Staphylococcus aureus is a variation of the bacterium Staphylococcus aureus, which has developed resistance to most antibiotics, making it difficult to treat and potentially deadly. Whilst the “Superbug” can be killed with detergents, detergent dilution and application is often inconsistent and ineffective, hence the bacteriophage route.
read more.


 

NanoSight receives £920,000 in new funding round to expand their nanoparticle characterization business

November 2008 - NanoSight Limited, the nanoparticle characterization company, is excited to announce the completion of a new round of financing which will provide £920,000 to enable the company to expand the business with the development of new products and sales channels in the US market.
read more.


 

NanoSight launches software enhancements at NanoTech Northern Europe for nanoparticle characterization systems

Salisbury, UK, September 2008 NanoSight Limited, the nanoparticle characterization company, has announced significant software advances for their family of instrumentation. New software versions usually offer fixes to problems and slight tweaks to existing routines in response to user requests. These advances provide particular benefits to users to improve the validity of their measurements.
read more


 

NanoSight adds temperature control to nanoparticle characterization systems

September 2008 - NanoSight Limited, the nanoparticle characterization company, have announced additional temperature control capability for their family of instrumentation.
read more.


 

The latest nanoparticle newsletter from NanoSight - NanoTrail now available

September 2008 - NanoSight Limited, the nanoparticle characterization company, has released the latest issue of their electronic newsletter. NanoTrail is an easy-to-access communication containing the latest news about NanoSight's users, products and applications.
read more.


 

NanoSight opens Western Region US office

August 2008 - NanoSight Limited, the nanoparticle characterization company, announced today that Duncan Griffiths has joined the company as Business Development Manager for the Western region of the USA. The company's nanoparticle characterization analysers, which are based uniquely on the visual tracking of nanoparticles, have shown superior performance to traditional analyzer systems, allowing a significantly better understanding of complex dispersions.
read more.


 

NanoSight opens US office

August 2008 - NanoSight Limited, the nanoparticle characterization company, has recently opened offices in the USA to provide local sales, applications and service support to their growing family of users. The office is located in Morganville, New Jersey approximately 25 miles from Newark's Liberty Airport. NanoSight will share facilities with the complementary US nanotechnology company, XiGo Nanotools, a company applying NMR technology for nanoparticle characterization.
read more.


 

NanoSight receives 100th system order for nanoparticle tracking analysis system

April 2008 - NanoSight Limited, the nanoparticle characterization company, has recently received their 100th purchase order for their unique nanoparticle tracking analysis system which counts individual particles in liquid. Professor Steffen Petersen of the University of Aalborg in Denmark has selected the NanoSight LM10 to study the build-up of multi-layered, targeted nanoparticle drug delivery systems.
read more.


request a call back

If you want to get in touch with our team email them here: enquiries@nanosight.com

Or for more information about us why not head over to our contact page for a full detail list.

Newsletter Signup

Join NanoTrail, NanoSight's electronic newsletter, to keep you informed of the latest news and product developments in particle sizing and characterisation.

sign up